Figure 9.Association between IAP family members and immunotherapy efficacy. (A) Comparative analysis of the IAP family members levels in Riaz cohorts of anti-PD-1/CTLA-4 responders and non-responders. (B) Patients in the Riaz cohorts’ ROC curve for the IAP family.
